CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company
NRX Pharmaceuticals, Inc.
Sign in to watch- Ticker
- NRXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822844431
- Phone
- 484-254-6134
- Business address
- 1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
- Former names
- Big Rock Partners Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-28 | Flynn Patrick John Director | Purchase | +2,500 | $1.25 | $3K | 37,709 |
| 2022-11-28 | Flynn Patrick John Director | Purchase | +2,500 | $1.24 | $3K | 40,209 |
| 2022-11-28 | Flynn Patrick John Director | Purchase | +1,750 | $1.25 | $2K | 1,750 |
| 2022-11-25 | VAN VOORHEES SETH CHIEF FINANCIAL OFFICER | Purchase | +8,716 | $1.12 | $10K | 8,716 |
| 2022-11-25 | VAN VOORHEES SETH CHIEF FINANCIAL OFFICER | Purchase | +600 | $1.10 | $660 | 9,316 |
| 2022-11-25 | VAN VOORHEES SETH CHIEF FINANCIAL OFFICER | Purchase | +7,021 | $1.11 | $8K | 16,337 |
| 2022-11-25 | VAN VOORHEES SETH CHIEF FINANCIAL OFFICER | Purchase | +8,716 | $1.12 | $10K | 8,716 |
| 2022-11-25 | VAN VOORHEES SETH CHIEF FINANCIAL OFFICER | Purchase | +600 | $1.10 | $660 | 9,316 |
| 2022-11-25 | VAN VOORHEES SETH CHIEF FINANCIAL OFFICER | Purchase | +7,021 | $1.11 | $8K | 16,377 |
| 2022-11-18 | Hurvitz Chaim Director | Purchase | +40,408 | $1.10 | $44K | 500,000 |
| 2022-11-18 | Hurvitz Chaim Director | Purchase | +40,408 | $1.10 | $44K | 500,000 |
| 2022-11-17 | Hurvitz Chaim Director | Purchase | +171,780 | $1.08 | $186K | 459,592 |
| 2022-11-17 | Hurvitz Chaim Director | Purchase | +171,780 | $1.08 | $186K | 459,592 |
| 2022-11-17 | Javitt Daniel C. 10% owner | Sale | −33,018 | $1.05 | $35K | 9,656,964 |
| 2022-11-16 | Hurvitz Chaim Director | Purchase | +287,812 | $0.99 | $285K | 287,812 |
| 2022-11-16 | Hurvitz Chaim Director | Purchase | +287,812 | $0.99 | $285K | 287,812 |
| 2022-11-16 | Javitt Daniel C. 10% owner | Sale | −133,719 | $1.02 | $136K | 9,689,982 |
| 2022-11-11 | Javitt Daniel C. 10% owner | Sale | −49,200 | $1.01 | $50K | 9,823,701 |
| 2022-10-21 | Gorovitz Aaron Director | Grant or award · Employee Stock Option | +162,660 | 162,660 | ||
| 2022-10-21 | Glied Sharon Director | Grant or award · Employee Stock Option | +162,660 | 228,097 |
Page 2 of 6 · 108 trades